IRIS
DEGIACOMI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.679
AS - Asia 1.152
EU - Europa 953
SA - Sud America 193
AF - Africa 69
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.611
CN - Cina 354
SG - Singapore 292
IE - Irlanda 245
VN - Vietnam 164
HK - Hong Kong 161
RU - Federazione Russa 152
BR - Brasile 149
IT - Italia 112
DE - Germania 111
FI - Finlandia 79
FR - Francia 69
GB - Regno Unito 52
ZA - Sudafrica 48
IN - India 45
CA - Canada 37
UA - Ucraina 29
JP - Giappone 23
MX - Messico 22
SE - Svezia 19
AT - Austria 16
BD - Bangladesh 15
PL - Polonia 14
TR - Turchia 14
IQ - Iraq 13
BE - Belgio 11
VE - Venezuela 11
CO - Colombia 10
ES - Italia 10
NL - Olanda 8
PK - Pakistan 8
EC - Ecuador 7
UZ - Uzbekistan 7
AR - Argentina 6
CZ - Repubblica Ceca 6
ID - Indonesia 6
PH - Filippine 6
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
IL - Israele 4
KR - Corea 4
TW - Taiwan 4
AO - Angola 3
AU - Australia 3
CL - Cile 3
LT - Lituania 3
LV - Lettonia 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
TN - Tunisia 3
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
LB - Libano 2
NP - Nepal 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CH - Svizzera 1
CM - Camerun 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MG - Madagascar 1
NA - Namibia 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 4.050
Salva come PNG Salva come JPEG
Città #
Dublin 245
San Jose 217
Chandler 185
Ashburn 176
Singapore 156
Hong Kong 150
Dallas 113
Beijing 93
Boardman 76
Los Angeles 63
Ho Chi Minh City 56
Helsinki 52
Munich 49
Pavia 48
Johannesburg 43
New York 43
Hanoi 42
Lauterbourg 41
Jacksonville 37
Nanjing 36
Council Bluffs 33
Lawrence 30
Medford 30
Princeton 30
Shanghai 30
Moscow 28
Santa Clara 25
Tokyo 21
Redondo Beach 20
Orem 17
Wilmington 17
São Paulo 15
The Dalles 14
Turku 14
Buffalo 13
Vienna 13
Nanchang 12
Warsaw 12
Chicago 10
Frankfurt am Main 10
London 10
Montreal 10
Nuremberg 10
Changsha 9
Chennai 9
Haiphong 9
Mexico City 9
Ottawa 9
Shenyang 9
Ann Arbor 8
Hangzhou 8
Phoenix 8
Piscataway 8
Stockholm 8
Brussels 7
Jiaxing 7
Milan 7
Paris 7
San Francisco 7
San Genesio ed Uniti 7
Biên Hòa 6
Boston 6
Cinisello Balsamo 6
Columbus 6
Falkenstein 6
Hebei 6
Hyderabad 6
New Delhi 6
Olomouc 6
Tashkent 6
Toronto 6
Atlanta 5
Charlotte 5
Chongqing 5
Da Nang 5
Houston 5
Istanbul 5
Manchester 5
Mumbai 5
Tianjin 5
Washington 5
Birmingham 4
Brooklyn 4
Bến Tre 4
Caracas 4
Erbil 4
Medellín 4
Naples 4
Rio de Janeiro 4
Seattle 4
Woodbridge 4
Achel 3
Amsterdam 3
Brasília 3
Curitiba 3
Dearborn 3
Denver 3
Draper 3
Fairfield 3
Fiorano Modenese 3
Totale 2.664
Salva come PNG Salva come JPEG
Nome #
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 163
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 159
Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals are Uniformly Susceptible to Benzothiazinones 144
A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors 143
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 130
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 130
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 127
A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis 123
A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis 119
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG. 113
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 111
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis 110
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 110
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 110
Pyridine-2-thiol 1-oxide derivatives and their use for treatment of mammalian infections caused by Mycobacterium or fungi 109
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 103
First triclosan-based macrocyclic inhibitors of InhA enzyme 103
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 99
Nitric oxide-releasing compounds for the treatment of lung infections 93
GarA is an essential regulator of metabolism in mycobacterium tuberculosis 93
Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound. 90
Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosis. 87
Age-related changes in PD-1 expression coincide with increased cytotoxic potential in Vδ2 T cells during infancy 85
Promoter mutagenesis for fine-tuning expression of essential genes in Mycobacterium tuberculosis 82
The antimalarial mefloquine shows activity against mycobacterium abscessus, inhibiting mycolic acid metabolism 81
Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options 80
Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression 77
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 76
Distinct Effects of Moxifloxacin and Bedaquiline on Growing and 'Non-Culturable' Mycobacterium abscessus 76
Concomitant assessment of PD-1 and CD56 expression identifies subsets of resting cord blood Vδ2 T cells with disparate cytotoxic potential 75
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 74
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. 73
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 72
Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium 71
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 71
The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo 68
Exploring the plasticity of the InhA substrate-binding site using new diaryl ether inhibitors 65
Micrococcin P1 – A bactericidal thiopeptide active against Mycobacterium tuberculosis 63
Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis 60
The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis 59
P146 New weapons are necessary to fight Mycobacterium abscessus 57
New Drugs and Novel Cellular Targets against Tuberculosis 51
Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes—Hydrazones with Antileishmanial and Antibacterial Activities 50
PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis 49
Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3 46
Whole cell screen based identification of spiropiperidines with potent antitubercular properties 42
Uncovering insights into the biology of Mycobacterium tuberculosis using genetic tools 16
Totale 4.188
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022141 5 1 1 0 2 2 5 14 8 5 14 84
2022/2023598 47 54 7 33 42 59 1 34 293 7 10 11
2023/2024300 50 52 8 16 18 54 12 28 5 15 26 16
2024/2025827 22 47 31 7 31 73 48 40 207 40 104 177
2025/20261.987 127 125 208 228 258 91 369 97 221 138 73 52
Totale 4.188